A Randomized, Controlled, Multi-center Collaborative Study to Evaluate the Efficacy of Magnesium Isoglycyrrhizinate Injection in the Prevention of Antineoplastic Chemotherapy Related Acute Liver Injury (MAGIC)

NCT01802996 Phase 4 UNKNOWN

This purpose of this study is to evaluate the evaluate the efficacy of Magnesium Isoglycyrrhizinate Injection in the prevention of antineoplastic chemotherapy related acute liver injury.

Details

Lead sponsor	Cttq
Phase	Phase 4
Status	UNKNOWN
Enrolment	2040
Start date	2013-03
Completion	2014-08

Conditions

• Neoplasms
• Liver Injury

Interventions

• Magnesium Isoglycyrrhizinate Injection

Primary outcomes

• The incidence of liver injury — 0-15 days
  anyone of ALT、AST、ALP、TBIL、DBIL、γ-GT\>ULN

Countries

China